NCT04605471View on ClinicalTrials.gov

A Study to Learn More About the Safety of Ultravist in Children and in the Elderly

CompletedOBSERVATIONAL
Enrollment

132,850

Participants

Timeline

Start Date

October 31, 2020

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
Hypersensitivity
Interventions
DRUG

Iopromide(Ultravist, BAY86-4877)

The study will be conducted by using pooled data of four company sponsored non-interventional studies with iopromide.

Trial Locations (1)

Unknown

Four company sponsored non-interventional studies with iopromide, Berlin

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY